Noah Rosenberg
2020
In 2020, Noah Rosenberg earned a total compensation of $1.7M as Chief Medical Officer at Retrophin, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $254,573 |
|---|---|
| Option Awards | $508,217 |
| Salary | $447,002 |
| Stock Awards | $432,880 |
| Other | $12,360 |
| Total | $1,655,032 |
Rosenberg received $508.2K in option awards, accounting for 31% of the total pay in 2020.
Rosenberg also received $254.6K in non-equity incentive plan, $447K in salary, $432.9K in stock awards and $12.4K in other compensation.
Rankings
In 2020, Noah Rosenberg's compensation ranked 6,397th out of 13,090 executives tracked by ExecPay. In other words, Rosenberg earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,397 out of 13,090 | 51st |
Division Manufacturing | 2,639 out of 5,621 | 53rd |
Major group Chemicals And Allied Products | 1,064 out of 2,254 | 53rd |
Industry group Drugs | 919 out of 1,954 | 53rd |
Industry Pharmaceutical Preparations | 687 out of 1,459 | 53rd |
Pay ratio
| Noah Rosenberg's Pay | $1,655,032 |
|---|---|
| Median Employee's Pay | $276,707 |
| Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Noah Rosenberg was $1,655,032.
The annual total compensation of the median employee at Retrophin was $276,707.
The ratio of Noah Rosenberg's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 16, 2021.
Rosenberg's colleagues
We found four more compensation records of executives who worked with Noah Rosenberg at Retrophin in 2020.